CD44 contributes to T cell activation.
Open Access
- 1 August 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 143 (3) , 798-801
- https://doi.org/10.4049/jimmunol.143.3.798
Abstract
We demonstrate here that the CD44 molecule, which mediates lymphocyte adhesion to high endothelial venules (HEV), is also involved in the delivery of an activation signal to the T cell. We have produced a CD44 mAb (H90) which is able to block the binding of lymphocytes to high endothelial venules. H90 had no effect on [3H]TdR incorporation of whole PBL stimulated by lectins, allogeneic cells, or CD3 mAb in the soluble phase; in contrast, it strongly increased [3H]TdR incorporation of PBL stimulated by CD2 pairs of mAb or by CD3 mAb linked to the plastic culture plates, when purified T cells were used, H90 mAb could efficiently induce them to proliferate after a primary signal of activation delivered via cross-linked CD3 or via CD2, an effect mediated by Il-2 synthesis and Il-2R expression. Thus, the effect of H90 mAb resembles the mitogenic effect of CD28 "9.3" mAb. However, several results show that CD28 and CD44 mediate different signals to the T cells: i) in contrast to CD28 mAb, CD44 mAb cannot complement the signal delivered by a soluble CD3 mAb, lectins, or PMA; ii) CD44 mAb, at the difference of CD28 mAb, cannot induce CD3+ thymocytes to proliferate in conjunction with a first signal provided via cross-linked CD3 or via CD2; iii) F(ab) fragments of H90 were efficient, whereas divalent fragments of CD29 9.3 mAb are required to produce activation signals; and iv) CD44 and CD28 mAb produce a very strong synergistic effect on T cell proliferation. These results fit with previous ones showing that endothelial cells can play the role of accessory cell in T cell activation and that a hierarchy of signaling can be delivered to T cells via CD3 and CD2.This publication has 19 references indexed in Scilit:
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.The Journal of Immunology, 1986
- Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.The Journal of Immunology, 1986
- A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes.The Journal of Immunology, 1986
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986
- Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.The Journal of Immunology, 1985
- Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells.The Journal of Immunology, 1985
- Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).The Journal of Experimental Medicine, 1985
- The heterogeneity and functional capacities of human thymocyte subpopulations.Proceedings of the National Academy of Sciences, 1984
- Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation.The Journal of Immunology, 1983